Not Rated
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(2.09% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 08-Oct-25 | 10115.70 | 1.16% | - | 0.91% | 129/239 |
1 Month | 15-Sep-25 | 10026.80 | 0.27% | - | 0.35% | 98/236 |
3 Month | 15-Jul-25 | 9910.50 | -0.90% | - | 0.57% | 137/227 |
6 Month | 15-Apr-25 | 10639.00 | 6.39% | - | 11.55% | 199/224 |
YTD | 01-Jan-25 | 9759.40 | -2.41% | - | 2.97% | 164/213 |
1 Year | 15-Oct-24 | 9762.10 | -2.38% | -2.38% | -1.87% | 101/196 |
2 Year | 13-Oct-23 | 15582.20 | 55.82% | 24.72% | 18.33% | 16/152 |
3 Year | 14-Oct-22 | 17381.10 | 73.81% | 20.19% | 19.92% | 54/127 |
5 Year | 15-Oct-20 | 19370.10 | 93.70% | 14.13% | 22.57% | 94/103 |
Since Inception | 28-Feb-19 | 29791.20 | 197.91% | 17.89% | 12.45% | 54/212 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 15-Oct-24 | 12000 | 12392.02 | 3.27 % | 6.12 % |
2 Year | 13-Oct-23 | 24000 | 27733.72 | 15.56 % | 14.57 % |
3 Year | 14-Oct-22 | 36000 | 48563.22 | 34.9 % | 20.42 % |
5 Year | 15-Oct-20 | 60000 | 89305.79 | 48.84 % | 15.9 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 85.9 | 10.08% | 0.35% | 10.73% (May 2025) | 9.72% (Aug 2025) | 53.85 k | 0.00 |
Apollo Hospitals Enterprises Ltd. | Hospital | 49.8 | 5.85% | 0.05% | 5.85% (Sep 2025) | 2.91% (Nov 2024) | 6.72 k | 0.00 |
Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 47.3 | 5.55% | 0.26% | 5.55% (Sep 2025) | 4.91% (Oct 2024) | 13.13 k | 0.00 |
Cipla Ltd. | Pharmaceuticals | 46.9 | 5.51% | -0.11% | 5.62% (Aug 2025) | 4.19% (Nov 2024) | 31.22 k | 0.00 |
Fortis Healthcare Ltd. | Hospital | 40.8 | 4.79% | 0.45% | 4.79% (Sep 2025) | 0% (Oct 2024) | 42.10 k | 0.00 |
Piramal Pharma Ltd. | Pharmaceuticals | 37.9 | 4.45% | 0.33% | 7.55% (Oct 2024) | 3.73% (Jul 2025) | 1.98 L | 0.00 |
Neuland Laboratories Ltd. | Pharmaceuticals | 35.3 | 4.14% | 0.46% | 4.24% (Nov 2024) | 3.11% (Apr 2025) | 2.41 k | 0.00 |
Divis Laboratories Ltd. | Pharmaceuticals | 35 | 4.11% | -0.16% | 4.84% (May 2025) | 3.92% (Dec 2024) | 6.16 k | 0.00 |
Aurobindo Pharma Ltd. | Pharmaceuticals | 33.9 | 3.98% | 0.34% | 4.57% (Apr 2025) | 0% (Oct 2024) | 31.30 k | 0.00 |
Alkem Laboratories Ltd. | Pharmaceuticals | 33.7 | 3.96% | 0.22% | 3.96% (Sep 2025) | 3.36% (Nov 2024) | 6.21 k | 0.00 |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 2.77% |
Net Receivables | Net Receivables | -0.60% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 406.67 | 2.34 | 24.66 | 82.81 | 42.08 | 39.86 |
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 266.19 | 0.39 | 9.43 | 25.89 | 25.50 | 19.25 |
Nippon India Japan Equity Fund - Growth | NA | 289.73 | -1.32 | 11.93 | 18.11 | 15.99 | 18.46 |
Franklin Asian Equity Fund - Growth | NA | 279.13 | 1.52 | 9.83 | 26.06 | 15.33 | 15.42 |
SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8693.07 | 2.95 | 1.72 | 12.07 | 14.17 | 20.29 |
DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1419.62 | 2.84 | 1.42 | 10.44 | 13.24 | 0.00 |
ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 311.03 | 4.09 | 1.17 | 8.44 | 12.47 | 14.85 |
Motilal Oswal Business Cycle Fund - Regular Plan - Growth | NA | 1984.52 | -1.20 | 2.41 | 13.61 | 12.47 | 0.00 |
Nippon India US Equity Opportunities Fund - Growth | NA | 724.35 | -0.13 | 4.89 | 18.61 | 11.81 | 22.56 |
Mirae Asset Banking and Financial Services Fund - Growth | NA | 2014.27 | 3.39 | 0.89 | 10.03 | 11.54 | 19.00 |
Out of 45 mutual fund schemes offered by this AMC, 2 is/are ranked 4 * , 10 is/are ranked 3 * , 10 is/are ranked 2 * , 5 is/are ranked 1 * , and 18 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
LIC MF Liquid Fund - Regular Plan - Growth | 2 | 11402.57 | 0.48 | 1.40 | 2.96 | 6.66 | 6.96 |
LIC MF Money Market Fund - Regular Plan - Growth | NA | 3130.05 | 0.55 | 1.45 | 3.37 | 6.73 | 6.38 |
LIC MF Large & Mid Cap Fund - Growth | 3 | 3046.84 | 0.14 | -1.17 | 8.76 | -3.61 | 16.82 |
LIC MF Nifty 8-13 yr G-Sec ETF | NA | 2248.29 | 0.72 | 0.57 | 2.44 | 8.22 | 9.10 |
LIC MF Nifty 8-13 yr G-Sec ETF | NA | 2248.29 | 0.71 | 0.52 | 2.37 | 8.04 | 8.89 |
LIC MF Banking & PSU Fund - Growth | 3 | 1909.36 | 0.87 | 1.21 | 3.31 | 7.84 | 7.53 |
LIC MF Multi Cap Fund - Regular Plan - Growth | NA | 1715.77 | 0.88 | 1.09 | 13.51 | -1.21 | 0.00 |
LIC MF Low Duration Fund - Growth | 3 | 1705.18 | 0.58 | 1.38 | 3.23 | 7.14 | 6.91 |
LIC MF Low Duration Fund - Growth | 3 | 1705.18 | 0.58 | 1.47 | 3.44 | 7.54 | 7.55 |
LIC MF Large Cap Fund - Growth | 2 | 1445.32 | 0.05 | -0.86 | 6.14 | -1.37 | 12.69 |